Table 3

Adjusted mean differences in plasma NfL concentrations between groups with 95% bias-corrected bootstrap CI

NfL C9orf72 PS C9orf72 S GRN PS GRN S MAPT PS MAPT S
Controls 9.0*
(1.3 to 26.8)
29.7**
(18.7 to 47.5)
0.0
(−3.1 to 3.3)
70.5**
(51.6 to 92.6)
0.9
(−2.2 to 6.4)
12.6*
(3.3 to 26.1)
C9orf72 PS 20.7*
(3.2 to 36.1)
9.0*
(−27.5 to −1.4)
61.4**
(37.7 to 82.7)
8.1*
(−27.0 to −0.6)
3.6
(−15.6 to 17.0)
C9orf72 S29.8**
(−47.7 to −18.7)
40.7**
(16.5 to 62.2)
28.9**
(−46.2 to −16.9)
17.2*
(−35.7 to −2.9)
GRN PS 70.5**
(52.5 to 92.2)
−0.9
(−5.9 to 2.9)
12.6*
(2.9 to 25.2)
GRN S69.6**
(−91.7 to −50.6)
57.9**
(−81.5 to −36.8)
MAPT PS 11.7*
(0.8 to 23.4)
  • Significant differences in bold: *p<0.05; **p<0.01.

  • NfL, neurofilament light chain; PS, presymptomatic; S, symptomatic.